Pre-Market Review: Vertex Pharma Inc., Orexigen Therapeutics Inc., MAKO Surgical Corp., and Alere Inc.

   Pre-Market Review: Vertex Pharma Inc., Orexigen Therapeutics Inc., MAKO
                        Surgical Corp., and Alere Inc.

Editor Note: For more information about this release, please scroll to bottom.

PR Newswire

LONDON, October 21, 2013

LONDON, October 21, 2013 /PRNewswire/ --

The U.S. equity market posted gains on Friday, October 18, 2013. All three
benchmark indexes edged higher, with the S&P 500, the Dow Jones Industrial
Average, and the NASDAQ Composite gaining 0.65%, 0.18% and 1.32% respectively.
Shares in the healthcare sector mostly ended on a higher note, tracking gains
in the broader market. The major movers in the sector included Vertex
Pharmaceuticals Inc. (NASDAQ: VRTX), Orexigen Therapeutics Inc. (NASDAQ:
OREX), MAKO Surgical Corporation (NASDAQ: MAKO), and Alere Inc. (NYSE: ALR).
AAAResearchReports.com initiated preliminary technical research on VRTX, OREX,
MAKO, and ALR. These free reports are accessible by signing today at:

http://www.aaaresearchreports.com/register/ 

On Friday, shares in Vertex Pharmaceuticals Inc. edged higher, extending the
gains from the previous trading session. The company's shares fluctuated
between $74.96 and $78.00 before finishing the day 0.26% higher at $77.06. A
total of 2.23 million shares were traded, which is marginally below the daily
average volume of 2.24 million. The company's shares have advanced 5.06% in
the previous three trading sessions, compared to a gain of 2.73% in the S&P
500 during the same period. Further, Vertex Pharmaceuticals Inc.'s stock is
trading above its 50-day and 200-day moving averages of $76.49 and $68.21,
respectively. The free technical analysis on VRTX is available by signing up
at:

http://www.AAAResearchReports.com/VRTX102113.pdf

Shares in Orexigen Therapeutics Inc. plummeted on Friday, finishing at $5.74,
down 3.53% from the previous day's closing price of $5.95. The company's
shares fluctuated between $5.59 and $6.05 during the trading session. A total
of 1.19 million shares were traded, which is marginally above the daily
average volume of 1.18 million. The company's shares have gained 2.87% in the
previous three trading sessions, compared to a gain of 2.73% in the S&P 500
during the same period. Additionally, Orexigen Therapeutics Inc.'s stock is
trading below its 50-day and 200-day moving averages of $6.57 and $6.27,
respectively. Register now to download free research on OREX at:

http://www.AAAResearchReports.com/OREX102113.pdf

On Friday, MAKO Surgical Corp.'s shares posted marginal gains, ending the day
at $29.76, which is 0.07% higher than the previous day's closing price of
$29.74. The company's shares fluctuated between $29.71 and $29.78 during the
trading session. A total of 1.55 million shares were traded, which is below
the daily average volume of 1.93 million. MAKO Surgical Corp.'s shares have
rallied 128.92% in the previous three months and 81.91% in the last one month,
outperforming the S&P 500, which has gained 3.10% and 2.02% during the
respective periods. Moreover, the company's stock is trading near its 52-week
high of $29.89 and also above its 50-day and 200-day moving averages of $20.51
and 13.98, respectively. A free report on MAKO can be accessed by registering
at:

http://www.AAAResearchReports.com/MAKO102113.pdf

Alere Inc.'s stock advanced 0.22% on Friday, tracking gains in the broader
market. The company's shares closed the day at $31.71, after oscillating
between $31.50 and $32.10 during the trading session. A total of 0.48 million
shares were traded, which is below the daily average volume of 0.65 million.
The company's shares have surged 13.90% in the previous three months,
outperforming the S&P 500, which has advanced 3.10% during the same period.
Further, Alere Inc.'s stock is trading above its 50-day and 200-day moving
averages of $31.62 and $26.66, respectively. Register with AAA Research
Reports and download research on ALR for free at:

http://www.AAAResearchReports.com/ALR102113.pdf

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
    only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

www.AAAresearchreports.com

SOURCE AAA Research Reports

Contact: Phone #: +1(646)396-9126, Contact Name: Peter F. Jones Email ID:
info@aaaresearchreports.com
 
Press spacebar to pause and continue. Press esc to stop.